Science Explorer Interactive view Map
Company · Tokushima · Japan

Taiho Pharmaceutical (Japan)

In research, Taiho Pharmaceutical (Japan) stands highest in Life Sciences (#6,947 of 14,347 worldwide), Medicine (#11,248 of 17,978 worldwide) and Health Sciences (#14,399 of 20,462 worldwide), over all time.

taiho.co.jp/english/index.htmlROR OpenAlex
World rank, all time
#15,037
of 42,892
Rank in Japan
#582
of 2,112
Research works
1.2k
▼ 22% vs 2013–17
Citations
24k
20.7 per fractional work
Top-10% rate
9.0%
record average 16.5%
Open access
42%
world 28%

What is Taiho Pharmaceutical (Japan) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Life SciencesDomain #6,947 of 14,347 7.0%462
MedicineField #11,248 of 17,978 8.8%478
Health SciencesDomain #14,399 of 20,462 8.6%492
Physical SciencesDomain #15,457 of 21,541 6.0%217
Biochemistry, Genetics and Molecular BiologyField #6,329 of 7,814 6.3%331
Molecular BiologySubfield #4,525 of 4,961 7.3%210
OncologySubfield #1,702 of 1,852 10.1%145

Each strip is that field’s whole ranked pool, with the notch where Taiho Pharmaceutical (Japan) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.55× its world share, 2 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.53× its world share, 17 worksBiochemistry, Geneti…Immunology and Microbiology: 4.55× its world share, 3 worksImmunology and Micro…Neuroscience: 0.41× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 4.27× its world share, 1 worksPharmacology, Toxico…Chemistry: 1.95× its world share, 2 worksChemistryComputer Science: 0.13× its world share, 1 worksComputer ScienceEngineering: 0.24× its world share, 2 worksEngineeringEnvironmental Science: 0.33× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.30× its world share, 1 worksMaterials SciencePhysics and Astronomy: 1.53× its world share, 2 worksPhysics and AstronomyHealth Professions: 1.02× its world share, 2 worksHealth ProfessionsMedicine: 2.26× its world share, 26 worksMedicineNursing: 0.39× its world share, 0 worksNursingBusiness, Management and Accounting: 0.18× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 0.14× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 5.5×. Every wedge is a field page.

Who are the top researchers at Taiho Pharmaceutical (Japan)?

Ranked on the composite score, Norio Ogata, Akihiro Hashimoto and Masakazu Fukushima lead among researchers whose main affiliation is Taiho Pharmaceutical (Japan).

  1. 1 Norio Ogata Japan · #235,489 worldwide 101 citations · 31 works
  2. 2 Akihiro Hashimoto Japan · #285,985 worldwide 182 citations · 23 works
  3. 3 Masakazu Fukushima Japan · #324,074 worldwide 98 citations · 41 works
  4. 4 Tetsuji Asao Japan · #1,049,561 worldwide 32 citations · 21 works
  5. 5 Kazuki Sakamoto Japan · #1,077,351 worldwide 69 citations · 47 works
  6. 6 Fumio Nakagawa Japan · #1,261,518 worldwide 35 citations · 21 works
  7. 7 Shuichi Ohkubo Japan · #1,318,980 worldwide 20 citations · 20 works
  8. 8 Hidekazu Miyake Japan · #1,460,602 worldwide 15 citations · 18 works
  9. 9 Teruhiro Utsugi Japan · #1,482,895 worldwide 27 citations · 20 works
All ranked researchers at Taiho Pharmaceutical (Japan)

Which keywords describe research at Taiho Pharmaceutical (Japan)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Cancer Therapy, Metabolism, Chemotherapy, Signaling, Targeted Therapy, Therapy and Immunotherapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer6▲ 7.8×12 topics
  2. Cancer Therapy5▲ 14×11 topics
  3. Metabolism5▲ 15×5 topics
  4. Chemotherapy4▲ 10×8 topics
  5. Signaling4▲ 114×2 topics
  6. Targeted Therapy3▲ 26×5 topics
  7. Immunotherapy3▲ 7.3×8 topics
  8. Therapy3▲ 27×3 topics
  9. Clinical Trials3▲ 7.3×4 topics
  10. Development3▲ 14×2 topics
  11. FGF213▲ 399×1 topic
  12. Fibroblast Growth Factor3▲ 399×1 topic
  13. Inflammation2▲ 2.0×13 topics
  14. Prognostic Factors2▲ 8.9×6 topics
  15. Genetic Mutations2▲ 8.2×6 topics
  16. Genomic Profiling2▲ 35×2 topics
  17. Monoclonal Antibodies2▲ 38×3 topics
  18. Mutation2▲ 18×3 topics
  19. Tumor Microenvironment2▲ 7.6×5 topics
  20. Monoclonal Antibody2▲ 63×2 topics
  21. Imatinib Mesylate2▲ 60×2 topics
  22. Treatment Guidelines2▲ 14×2 topics
  23. Glycosylation2▲ 26×3 topics
  24. ALK Inhibitors2▲ 40×1 topic
  25. Biopharmaceuticals2▲ 49×2 topics
  26. EGFR Mutations2▲ 40×1 topic
  27. Immunogenicity2▲ 59×2 topics
  28. Anticancer Agents1▲ 16×4 topics
  29. Cell Proliferation1▲ 27×3 topics
  30. Cell Signaling1▲ 16×8 topics
  31. Innate Immunity1▲ 7.1×3 topics
  32. Therapeutic Antibodies1▲ 32×2 topics
  33. Fusion Genes1▲ 87×1 topic
  34. Hypereosinophilic Syndrome1▲ 87×1 topic
  35. PET Imaging1▲ 12×4 topics
  36. BCR-ABL1▲ 68×1 topic
  37. Breast Cancer1▲ 7.8×3 topics
  38. Cell Division1▲ 88×1 topic
  39. Imatinib1▲ 68×1 topic
  40. Microtubules1▲ 88×1 topic

Which research topics does Taiho Pharmaceutical (Japan) publish most on?

By volume in 2022–2025: Fibroblast Growth Factor Research, Lung Cancer Treatments and Mutations, Eosinophilic Disorders and Syndromes and Colorectal Cancer Treatments and Studies.

Fibroblast Growth Factor…3Fibroblast Growth Factor Research: 3 fractional worksLung Cancer Treatments and Mutations: 2 fractional worksEosinophilic Disorders and Syndromes: 1 fractional worksColorectal Cancer Treatments and Studies: 1 fractional worksMicrotubule and mitosis dynamics: 1 fractional worksChronic Myeloid Leukemia Treatments: 1 fractional worksCancer Immunotherapy and…1Cancer Immunotherapy and Biomarkers: 1 fractional worksPI3K/AKT/mTOR signaling in cancer: 1 fractional worksHER2/EGFR in Cancer Research: 1 fractional worksViral Infectious Disease…1Viral Infectious Diseases and Gene Expression in Insects: 1 fractional works
Molecular BiologyPulmonary and Respiratory MedicineRheumatologyOncology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Fibroblast Growth Factor Research Molecular Biology 3 works
  2. 2 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
  3. 3 Eosinophilic Disorders and Syndromes Rheumatology 1 works
  4. 4 Colorectal Cancer Treatments and Studies Oncology 1 works
  5. 5 Microtubule and mitosis dynamics Cell Biology 1 works
  6. 6 Chronic Myeloid Leukemia Treatments Hematology 1 works
  7. 7 Cancer Immunotherapy and Biomarkers Oncology 1 works
  8. 8 PI3K/AKT/mTOR signaling in cancer Molecular Biology 1 works
  9. 9 HER2/EGFR in Cancer Research Oncology 1 works
  10. 10 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available41.5%not open58.5%

World: 28% of research is openly available.

with international co-authors10.8%domestic only89.2%

World: 19% is written across borders.

How has Taiho Pharmaceutical (Japan)'s research output changed?

Output in 2018–2022 was 22% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Tokushima

All research institutions in Tokushima

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.